Citation Impact
Citing Papers
Emerging organic contaminants in groundwater: A review of sources, fate and occurrence
2012 Standout
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment
2006 Standout
Effects of the presence of sulfonamides in the environment and their influence on human health
2011 Standout
Effects of the tricothecene mycotoxin diacetoxyscirpenol on fertility and hatchability of broiler breeders
1999
Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction
1998
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
The role of the Epstein-barr virus in human disease
2002
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Dendritic Cells Expand Epstein Barr Virus Specific CD8+ T Cell Responses More Efficiently Than EBV Transformed B Cells
2005 StandoutNobel
New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
2008 Standout
Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels
2000
Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
2007
The ubiquitin/proteasome system in Epstein–Barr virus latency and associated malignancies
2002
Epstein-Barr virus: exploiting the immune system
2001 Standout
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Immunotherapeutic Strategies for High-Risk Bladder Cancer
2007 StandoutNobel
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Toxicity, metabolism, and impact of mycotoxins on humans and animals
2001 Standout
Nasopharyngeal carcinoma
2015 Standout
Occurrence, fate and effects of pharmaceutical substances in the environment- A review
1998 Standout
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Epstein–Barr virus: 40 years on
2004 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
Ecotoxicology of human pharmaceuticals
2005 Standout
Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review
2012 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review
2012 Standout
Cancer and the chemokine network
2004 Standout
Occurrence of antibiotics in the aquatic environment
1999 Standout
Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions
2007
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Exosomes: composition, biogenesis and function
2002 Standout
Epstein–Barr Virus Infection
2000 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data
2002 Standout
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
1998 Standout
Epstein-Barr virus infection and human malignancies.
2001
Role of Cytotoxic T Lymphocytes in Epstein-Barr Virus-Associated Diseases
2000
Occurrence and Fate of the Cytostatic Drugs Cyclophosphamide and Ifosfamide in Wastewater and Surface Waters
2006 Standout
Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance
2002 Standout
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients
2006
The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
2007 Standout
HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
1997
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Streams in the Urban Landscape
2001 Standout
Immunohistochemical Detection of the Epstein-Barr Virus–Encoded Latent Membrane Protein 2A in Hodgkin's Disease and Infectious Mononucleosis
1997
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
2003
Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Treatment of Patients With EBV-Positive Relapsed Hodgkin's Disease
1998
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge
2003
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Pharmaceuticals and personal care products in the environment: agents of subtle change?
1999 Standout
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Drugs in the environment
2000
Type 2 Cytokines Predominate in the Human CD4+T-Lymphocyte Response to Epstein-Barr Virus Nuclear Antigen 1
2000
Deficient Major Histocompatibility Complex Class II Antigen Presentation in a Subset of Hodgkin's Disease Tumor Cells
1998
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
2000 StandoutNobel
Epstein‐Barr virus infection and human malignancies
2001
The role of cytokines in classical Hodgkin lymphoma
2002
Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1
2000
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing
2000
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.
2002
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of M.K. ECKMAN being referenced
Chemicals Used by the Poultry Industry
1994
Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease
1995
Factors Affecting Broiler Breeder Performance
1981